Aberrant Activation of Arachidonic Acid and Eicosanoid Pathways-Targets for Treating Prostate Cancer

E-ISSN： 2212-3334|2|1|9-15

ISSN： 1872-2148

Source： Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol.2, Iss.1, 2008-01, pp. : 9-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Patents on Interventional Robot for Prostate Cancer

Recent Patents on Mechanical Engineering, Vol. 9, Iss. 4, 2017-01 ,pp. : 281-288

Bentham Science Publishers

Access to resources Recommend Favorite

Prostate Cancer Gene Expression Marker 1 (PCGEM1): A Patented Prostate- Specific Non-Coding Gene and Regulator of Prostate Cancer Progression

Recent Patents on DNA & Gene Sequences, Vol. 3, Iss. 3, 2009-11 ,pp. : 151-163

Bentham Science Publishers

Access to resources Recommend Favorite

Prospective Trial of an Herbal Formula BYSH and Saw Palmetto in Patients with Hormonal Refractory Prostate Cancer: A Pilot Study

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 8, Iss. 3, 2014-09 ,pp. : 196-202

Bentham Science Publishers

Access to resources Recommend Favorite

Medical Image Processing Technology for Diagnosing and Treating Cancers

By Shih Frank Y. Tse Joanne S.

Recent Patents on Biomedical Engineering, Vol. 2, Iss. 2, 2009-06 ,pp. : 141-147

Bentham Science Publishers

Access to resources Recommend Favorite

Claims of Current Inhaled Corticosteroid Patents for Treating Asthma

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 1, Iss. 2, 2007-06 ,pp. : 146-150

Bentham Science Publishers

Access to resources Recommend Favorite